MedPath
FDA Product

Nalfon

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Nalfon

55700-853

Regulatory Information

55700-853

NDA017604

C73594

March 31, 2020

USA

These highlights do not include all the information needed to use NALFON safely and effectively. See full prescribing information for NALFON. NALFON (fenoprofen calcium, USP) capsules, for oral use Initial U.S. Approval: 1982

HUMAN PRESCRIPTION DRUG LABEL

2

Company Information

831276758

Active Ingredients

CROSPOVIDONE

Code: 2S7830E561

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

SODIUM LAURYL SULFATE

Code: 368GB5141J

Class Code: IACT

TALC

Code: 7SEV7J4R1U

Class Code: IACT

GELATIN

Code: 2G86QN327L

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

FD&C YELLOW NO. 6

Code: H77VEI93A8

Class Code: IACT

FENOPROFEN CALCIUM

Quantity: 400 mg in 1 1

Code: 0X2CW1QABJ

Class Code: ACTIM

D&C YELLOW NO. 10

Code: 35SW5USQ3G

Class Code: IACT

FD&C BLUE NO. 1

Code: H3R47K3TBD

Class Code: IACT

FD&C RED NO. 40

Code: WZB9127XOA

Class Code: IACT

Active Moieties

FENOPROFEN

Code: RA33EAC7KY

© Copyright 2025. All Rights Reserved by MedPath